View on Pubmed.gov 35456041 | View on doi.org 10.3390/cells11...
Mechanistic Insights into the Link between Gut Dysbiosis and Major Depression: An Extensive Review.
- Department of Pharmacology, JSS College of Pharmacy, JSS Academy of Higher Education & Research, Mysuru 570015, Karnataka, India. Centre for Experimental Pharmacology and Toxicology, Central Animal Facility, JSS Academy of Higher Education & Research, Mysuru 570015, Karnataka, India.
- Department of Pharmacology, JSS College of Pharmacy, JSS Academy of Higher Education & Research, Mysuru 570015, Karnataka, India.
- Centre for Experimental Pharmacology and Toxicology, Central Animal Facility, JSS Academy of Higher Education & Research, Mysuru 570015, Karnataka, India.
- Food and Brain Research Foundation, Chennai 600094, Tamil Nadu, India.
- Section of Molecular Pharmacology and Toxicology, Laboratory of Membrane Biochemistry and Biophysics, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Rockville, MD 20892, USA.
- Department of Food Science and Nutrition, CAMS, Sultan Qaboos University, Muscat 123, Oman.
- Aging and Dementia Research Group, Sultan Qaboos University, Muscat 123, Oman.
- Q3CG Research Institute (QRI), Research and Policy Division, 7227 Rachel Drive, Ypsilant, MI 48917, USA.
Abstract
Depression is a highly common mental disorder, which is often multifactorial with sex, genetic, environmental, and/or psychological causes. Recent advancements in biomedical research have demonstrated a clear correlation between gut dysbiosis (GD) or gut microbial dysbiosis and the development of anxiety or depressive behaviors. The gut microbiome communicates with the brain through the neural, immune, and metabolic pathways, either directly (via vagal nerves) or indirectly (via gut- and microbial-derived metabolites as well as gut hormones and endocrine peptides, including peptide YY, pancreatic polypeptide, neuropeptide Y, cholecystokinin, corticotropin-releasing factor, glucagon-like peptide, oxytocin, and ghrelin). Maintaining healthy gut microbiota (GM) is now being recognized as important for brain health through the use of probiotics, prebiotics, synbiotics, fecal microbial transplantation (FMT), etc. A few approaches exert antidepressant effects via restoring GM and hypothalamus-pituitary-adrenal (HPA) axis functions. In this review, we have summarized the etiopathogenic link between gut dysbiosis and depression with preclinical and clinical evidence. In addition, we have collated information on the recent therapies and supplements, such as probiotics, prebiotics, short-chain fatty acids, and vitamin B12, omega-3 fatty acids, etc., which target the gut-brain axis (GBA) for the effective management of depressive behavior and anxiety.
References
BMC Microbiol. 2016 May 25;16:90
Neurosci Biobehav Rev. 2014 Sep;45:46-62
Benef Microbes. 2018 Dec 7;9(6):855-864
Psychiatry Investig. 2020 Jan;17(1):2-8
Cited by 106 citations (total)
Journal Article Review
Gut Dysbiosis and Fecal Microbiota Transplantation in Autoimmune Diseases.
Electronic publication date September 28, 2022
Paulina Belvoncikova [...] Roman Gardlik et al.
Gut microbiota dysbiosis has recently been reported in a number of clinical states, including neurological, psychiatric, cardiovascular, metabolic and autoimmune...
Journal Article Review
Critical Review of the Cross-Links Between Dietary Components, the Gut Microbiome, and Depression.
Electronic publication date January 25, 2025
Nidesha Randeni [...] Baojun Xu et al.
The complex relationship between diet, the gut microbiota, and mental health, particularly depression, has become a focal point of contemporary...
Conflict of interest statement
MeSH
- •
- •
- •
- •
- •
- •
- •
- •
- •
- •
- •
- •
- •
Specialties
- •
- •
- •
- •
- •
- •
- •
- •
- •
- •
- •